Choriogonadotropin alfa - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
Product details |
Supply Impact Dates |
Further Details |
OVIDREL choriogonadotropin alfa (rch) 250 microgram/ 0.5mL solution for injection pre-filled pen AUST R: 170446Active ingredients:
Choriogonadotropin alfa
Dosage form: Injection, solution
Sponsor: Merck Healthcare Pty Ltd
Phone: 1800 257 348
|
From 01 Jul 2024 to 30 Jun 2025
|
Shortage status: Current
Availability: Emergency Supply Only
Reason: Unexpected increase in consumer demand
Management action: The sponsor is closely controlling the supply. An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-sl9a-index and search for the active ingredient.
|